Drugs / Probiotic with Human Milk Oligosaccharides (HMO)
Probiotic with Human Milk Oligosaccharides (HMO)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06791993 | Feb → Aug 2025 overdue | immune dysregulation, neurodevelopmental defects, and colitis | Acibadem Maslak Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic with Human Milk Oligosaccharides (HMO) | “Probiotic with Human Milk Oligosaccharides (HMO)” NCT06791993 ↗ |
| Modality | Other / unclassified | “a dual-strain probiotic containing Human Milk Oligosaccharides (HMO)” NCT06791993 ↗ |
| Route | Oral | “The probiotic will be administered orally twice daily” NCT06791993 ↗ |